Where does Migal Galilee Research Institute Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Migal Galilee Research Institute Ltd. ranks #48,750 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Migal Galilee Research Institute Ltd. hold?

Migal Galilee Research Institute Ltd. holds 5 US utility patents granted between 2021 and 2024, spanning 8 technology areas.

What is Migal Galilee Research Institute Ltd.'s Innovation Score?

Migal Galilee Research Institute Ltd. has an Innovation Score of 44.8 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Migal Galilee Research Institute Ltd. focus on?

Migal Galilee Research Institute Ltd.'s top technology area is C07D (Heterocyclic Compounds) with 2 patents, ranking #2,199 of 3,165 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Migal Galilee Research Institute Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Migal Galilee Research Institute Ltd..

What does claim depth mean for Migal Galilee Research Institute Ltd.'s patents?

Migal Galilee Research Institute Ltd.'s patents average 14.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Migal Galilee Research Institute Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Migal Galilee Research Institute Ltd.

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Migal ranks #48,750 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#48,750
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.8/100): 14.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R48750 · Foreign Corporation #48,750 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,750/49,997
PHOTO-FINISH Microsystems
CPC-NARROW C07D · 8 areas
INNOV-PAR 44.8/100
CLAIMS-RICH 14.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2024 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Microsystems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Migal’s 44.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (14%) Velocity 20.0 pts (45%) Breadth 10.0 pts (22%) Claim depth 8.6 pts (19%)

Qualcomm Incorporated · highest

85
Migal Galilee… · this assignee

45
3D Lighting… · lowest

7

What this shows Migal's Innovation Score is 44.8/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Migal?

Each dot is one of Migal’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Migal’s own 14.4 claims/patent is ABOVE the 9.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Migal vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Migal's grants concentrate

Migal Galilee Research Institute Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 40% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2021. By volume, Migal sits between Microsystems, Inc. and Milabs B.V..

Migal's three-year grant acceleration

Migal Galilee Research Institute Ltd. shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Microsystems

5
Microtechnologies

5
Midnight Madness…

5
Midwest Apple Imp…

5
Miguel Torres

5
Mikasa Sangyo

5
Mikron Agno

5
Milabs B V

5
Migal Galilee Res… ◀

5

What this shows Migal holds 5 patents at rank #48,635, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Migal

By rank, the assignees closest to #48,635 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Migal's primary technology class.

Migal's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Migal Galilee Research Institute Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	20.0%
2023	3	60.0%
2024	1	20.0%

Which technologies does Migal Galilee Research Institute Ltd. patent most?

C07D - Heterocyclic Compounds 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C12Y - Enzymes 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

A01C - PLANTING; SOWING; Fertilising 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Migal Galilee Research Institute Ltd.'s patent record in context - here's where to go next.

Migal Galilee Research Institute Ltd.'s lead technology class is C07D (Heterocyclic Compounds), 40% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #48,750 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Migal Galilee Research Institute Ltd. against Microsystems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.